Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY6 | Q15077 | 8/20 | 0.69 |
| ▸ | P2RY2 | P41231 | 12/20 | 0.68 |
| ▸ | P2RY4 | P51582 | 7/20 | 0.68 |
| ▸ | P2RY14 | Q15391 | 6/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Uridine_Diphosphate SCHEMBL27780277 | 1.00 | P2RY6 (0.69) | P2RY6P2RY2P2RY4P2RY14 | |
| Uridine Triphosphate SCHEMBL28049330 | 0.98 | P2RY2 (0.71) | P2RY6P2RY2P2RY4P2RY14 | |
| Uridine_Diphosphate SCHEMBL454080 | 0.98 | P2RY6 (0.69) | P2RY6P2RY2P2RY4P2RY14 | |
| Uridine_Diphosphate SCHEMBL20553195 | 0.98 | P2RY6 (0.69) | P2RY6P2RY2P2RY4P2RY14 | |
| Uridine_Diphosphate SCHEMBL667655 | 0.98 | P2RY6 (0.69) | P2RY6P2RY2P2RY4P2RY14 | |
| Uridine_Diphosphate SCHEMBL4311732 | 0.98 | P2RY6 (0.69) | P2RY6P2RY2P2RY4P2RY14 | |
| Uridine_Diphosphate SCHEMBL27785901 | 0.98 | P2RY6 (0.69) | P2RY6P2RY2P2RY4P2RY14 | |
| Uridine_Diphosphate SCHEMBL23923917 | 0.98 | P2RY6 (0.68) | P2RY6P2RY2P2RY4P2RY14 | |
| Uridine_Diphosphate SCHEMBL8740673 | 0.98 | P2RY6 (0.68) | P2RY6P2RY2P2RY4P2RY14 | |
| Uridine_Diphosphate SCHEMBL28303416 | 0.98 | P2RY6 (0.68) | P2RY6P2RY2P2RY4P2RY14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240418701-A1 | SINGLE MOLECULE IDENTIFICATION WITH A REACTIVE HETERO-NANOPORE | NANJING UNIVERSITY (CN) | 2024-12-19 | — | — | US | claimed |
| CN-118497767-A | Low-metal-ion-residue chip post-CMP cleaning agent and preparation method and application thereof | 浙江奥首材料科技有限公司 | 2024-08-16 | — | — | CN | claimed |
| EP-4413379-A1 | SINGLE MOLECULE IDENTIFICATION WITH A REACTIVE HETERO-NANOPORE | Nanjing University (CN) | 2024-08-14 | — | — | EP | claimed |
| CN-118103711-A | Single molecule identification with reactive heterogeneous nanopores | 南京大学 | 2024-05-28 | — | — | CN | claimed |
| CN-117683833-A | Method for preparing nucleotide sugar from nucleoside monophosphate | 山东大学 | 2024-03-12 | — | — | CN | claimed |
| CN-117487774-A | Application of UGT94X1 as catalyst in preparation of triterpenoid saponin | 上海中医药大学 | 2024-02-02 | — | — | CN | claimed |
| CN-117467633-A | Application of UGT71A3 as catalyst in preparation of triterpenoid saponin | 上海中医药大学 | 2024-01-30 | — | — | CN | claimed |
| US-20230192748-A1 | Etoposide Glycosides, Methods Of Making, And Uses Thereof As An Anti-Cancer Drug | DOUBLERAINBOW BIOSCIENCES INC. | 2023-06-22 | — | — | US | claimed |
| US-20230193336-A1 | ENASIDENIB GLYCOSIDES AND METHODS OF TREATING DISEASES ASSOCIATED WITH ISOCITRATE DEHYDROGENASE (IDH) DYSFUNCTION | DOUBLERAINBOW BIOSCIENCES INC. | 2023-06-22 | — | — | US | claimed |
| US-20230124589-A1 | Ivacaftor Glycosides, Methods Of Making, And Uses Thereof In Treating Cystic Fibrosis | DOUBLERAINBOW BIOSCIENCES INC. | 2023-04-20 | — | — | US | claimed |
| CN-107164355-B | Uridine-5' -diphosphate galactose epimerase derived from star-of-Bethlehem, nucleotide sequence and application thereof | 中国医学科学院药物研究所 | 2020-03-31 | — | — | CN | claimed |
| CN-103954701-B | HPLC is utilized to detect the method for β-Isosorbide-5-Nitrae-xylose transferase activity in xylan synthesis | SOUTH CHINA AGRICULTURAL UNIVERSITY (CN) | 2015-12-09 | — | — | CN | claimed |
| CN-103954701-A | Method for detecting activity of beta-1,4-xylosyltransferase in xylan synthesis by utilizing high performance liquid chromatography (HPLC) | UNIV SOUTH CHINA AGRICULT | 2014-07-30 | — | — | CN | claimed |
| CN-101698839-B | uridine diphosphate xylose isomerase, coding gene and application thereof | UNIV BEIJING | 2012-05-23 | — | — | CN | claimed |
| CN-101698839-A | Uridine diphosphate xylose isomerase, coding gene thereof and use thereof | UNIV BEIJING | 2010-04-28 | — | — | CN | claimed |
| US-20040018964-A1 | Glycosyltransferase gene gtfE from Amycolatopsis orientalis | ELI LILLY AND COMPANY | 2004-01-29 | — | — | US | claimed |
| EP-1292691-A2 | CIS-ZEATIN O-GLCOCYLTRANSFERASE FROM ZEA MAYS | The State of Oregon acting by and through The State Board of Higher Education on behalf of Oregon State University (US) | 2003-03-19 | — | — | EP | claimed |
| US-20020155567-A1 | Glycosyltransferase gene gtfE from amycolatopsis oreintalis | BALTZ RICHARD H (US) | 2002-10-24 | — | — | US | claimed |
| WO-2001094564-A2 | CIS-ZEATIN O-GLCOCYLTRANSFERASE FROM ZEA MAYS | THE STATE OF OREGON ACTING BY AND THROUGH THE STATE BOARD OF HIGHER EDUCATION ON BEHALF OF OREGON STATE UNIVERSITY (US) | 2001-12-13 | — | — | WO | claimed |
| US-6232102-B1 | GLYCOSYLATING A GLYCOPEPTIDE BY CONTACTING WITH ENZYME OF DEFINED AMINO ACID SEQUENCE WHICH HAS PROLINE AT POSITION 335 REPLACED BY SERINE; ANTIBIOTICS | ELI LILLY AND COMPANY | 2001-05-15 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230124589-A1 | Ivacaftor Glycosides, Methods Of Making, And Uses Thereof In Treating Cystic Fibrosis | UGGT1, UGDH, GALE | P2RY6 1010/4885P2RY2 2808/4885P2RY4 1505/4885 |
| US-20020155567-A1 | Glycosyltransferase gene gtfE from amycolatopsis oreintalis | UGGT1, GALNT6, OGT | P2RY6 4205/4885P2RY2 4744/4885P2RY4 4790/4885 |
| US-20230193336-A1 | ENASIDENIB GLYCOSIDES AND METHODS OF TREATING DISEASES ASSOCIATED WITH ISOCITRATE DEHYDROGENASE (IDH) DYSFUNCTION | UGDH, IDH1, G6PD | P2RY6 2158/4885P2RY2 3532/4885P2RY4 3391/4885 |
| US-20230192748-A1 | Etoposide Glycosides, Methods Of Making, And Uses Thereof As An Anti-Cancer Drug | GALE, UGGT1, DERA | P2RY6 2553/4885P2RY2 4590/4885P2RY4 4234/4885 |
| US-20040018964-A1 | Glycosyltransferase gene gtfE from Amycolatopsis orientalis | UGGT1, GALNT6, GALNT1 | P2RY6 4183/4885P2RY2 4704/4885P2RY4 4789/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.